Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The target cells for released Interleukin-22 (IL-22) are the Enterocytes / Intestinal Epithelial Cells (IECs)
IL-22 confers protection via the STAT3 signal transduction pathway by inducing the production of other antimicrobial peptides such as BD-2, BD-3, Calcium-Binding Protein A7 (S100A7), [Calcium-Binding Prot…